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Abstract
Background: Collagens require the hydroxylation of proline (Pro) residues in their triple-helical domain repeating
sequence Xaa-Pro-Gly to function properly as a main structural component of the extracellular matrix in animals
at physiologically relevant conditions. The regioselective proline hydroxylation is catalyzed by a specific prolyl
4-hydroxylase (P4H) as a posttranslational processing step.
Results: A recombinant human collagen type I a-1 (rCIa1) with high percentage of hydroxylated prolines (Hyp)
was produced in transgenic maize seeds when co-expressed with both the a- and b- subunits of a recombinant
human P4H (rP4H). Germ-specific expression of rCIa1 using maize globulin-1 gene promoter resulted in an average
yield of 12 mg/kg seed for the full-length rCIa1 in seeds without co-expression of rP4H and 4 mg/kg seed for the
rCIa1 (rCIa1-OH) in seeds with co-expression of rP4H. High-resolution mass spectrometry (HRMS) analysis revealed
that nearly half of the collagenous repeating triplets in rCIa1 isolated from rP4H co-expressing maize line had the
Pro residues changed to Hyp residues. The HRMS analysis determined the Hyp content of maize-derived rCIa1-OH
as 18.11%, which is comparable to the Hyp level of yeast-derived rCIa1-OH (17.47%) and the native human CIa1
(14.59%), respectively. The increased Hyp percentage was correlated with a markedly enhanced thermal stability of
maize-derived rCIa1-OH when compared to the non-hydroxylated rCIa1.
Conclusions: This work shows that maize has potential to produce adequately modified exogenous proteins with
mammalian-like post-translational modifications that may be require for their use as pharmaceutical and industrial
products.
Background
Collagen is the most abundant protein found in animals.
It has been used widely for industrial and medical appli-
cations such as drug delivery and tissue engineering
[1,2]. Human type I collagen is the most abundant col-
lagen type in the human body and is also one of the
most studied collagen types. It is a heterotrimer com-
posed of two a1( C I a1) and one a2( C I a2) chains with
the helical region composed by a repeating composition
of Xaa-Yaa-Gly, where X and Y are typically proline
(Pro) and hydroxyproline (Hyp) [3]. Collagens used
commercially are traditionally extracted from animal
tissues. These products contain different types of col-
lagen and may be contaminated with potential immuno-
genic and infective agents considered hazardous to
human health. Thus, recombinant technology has been
developed to produce high quality and animal derived
contaminant-free collagens. Recombinant collagens have
been produced in mammalian cells [4], insect cell cul-
tures [5], yeast [6], and plant cell culture [2,7].
Transgenic plant systems have advantages over other
recombinant production systems in terms of lower cost,
higher capacity, lower infective agents/toxins contamina-
tion risk, and inexpensive storage capability facilitating
processing [8,9]. The production of plant derived
recombinant collagen I a-1 (rCIa1) was reported in
2000 using tobacco [10] and tobacco cell culture [2]. * Correspondence: kanwang@iastate.edu
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A challenge for producing rCIa1 in non-mammalian
e x p r e s s i o ns y s t e m ss u c ha st r a n s g e n i cp l a n t si st h e
resulting low regioselective hydroxyproline content that
makes the product unstable at physiologically relevant
temperatures. In humans the 4-hydroxyproline residues
synthesized by prolyl 4-hydroxylases (P4Hs) as a post-
translational modification increase the stability of the
collagen triple helix structure [14]. The stability of the
collagen is increased with the presence of the hydroxy-
proline primarily through stereoelectronic effects [15].
On the other hand, the hydroxyproline content for the
rCIa1 is almost zero in transgenic tobacco [10], or very
low in transgenic maize [11] when rCIa1i sn o tc o -
expressed with P4H. Since the insect, microbial and
plant endogenous P4Hs are not able to achieve the
same level of hydroxylation of rCIa1a sp r e s e n ti nt h e
human CIa1 chain, the co-expression with collagen of a
recombinant animal P4H (rP4H) is necessary to increase
t h eh y d r o x y p r o l i n ec o n t e n to ft h er C I a1t od e l i v e ra
stable product. In tobacco, co-expression of P4H with
an a subunit from C. elegans and a b subunit from
mouse [16] or a recombinant human P4H [17] led to
increased hydroxyproline levels of the rCIa1. Similar
results were seen in tobacco cell culture [2]. However,
the tobacco-derived collagen still had lower Hyp content
compared to native human CIa1m a k i n gt h i sp r o d u c t
unsuitable for use in many applications.
In this study, we generated transgenic maize lines
expressing the human rCIa1 gene alone or lines co-
expressing both rCIa1 and rP4H genes. Using high-
resolution mass spectrometry (HRMS) analysis, we mea-
sured the percentages of Hyp and Pro residues in the
rCIa1 protein extracted from transgenic maize seeds as
well as the actual positions of hydoxylated prolines. We
also performed in vitro pepsin treatment at different
temperatures to compare the thermal stabilities of
maize-derived hydroxylatedo rn o n - h y d r o x y l a t e dr C I a1
proteins. Here, we report for the first time that by
co-expressing rP4H genes, maize can produce rCIa1
with a hydroxyproline content comparable to native
human type I collagen. This achievement provides
further confirmation that maize seeds can be used to
produce exogenous proteins that require mammalian-
like posttranslational modifications for use in specific
applications.
Results
Generation of maize lines expressing rCIa1 with and
without rP4H co-expression in seeds
The constructs used in this study are shown in Figure 1.
The CGB construct carries a gene encoding a recombi-
nant full-length human collagen type I, rCIa1, and the
CGD construct carries the rCIa1g e n ea n db o t ha and
b subunits of recombinant human prolyl 4-hydroxylase,
rP4Ha and rP4Hb. The rCIa1 gene was partially maize
codon-optimized and its expression was driven by a
maize embryo specific globulin-1 promoter (Pglb, [18]).
A barley alpha amylase signal sequence (BAASS, [19])
was used as a substitute for the human CIa1 signal pep-
tide (UniProtKB/Swiss-Prot: P02452 [1-22]). The combi-
nation of embryo specific promoter and the BAASS has
demonstrated high expression of foreign proteins in
maize seed [20-22]. The rCIa1 gene lacks the N-propep-
tide but contains the telopeptide sequences both at the
N and C terminal regions. A 29 amino acid bacterioph-
age T4 fibritin foldon peptide sequence [23] was fused
at the C-terminus to the rCIa1 replacing the C-propep-
tide. The foldon, as the native C-propeptide, facilitates
the rCIa1 triple-helical assembly and enhances its stabi-
lity [23]. To avoid undesired DNA rearrangement
caused by using identical sequences (such as using same
promoters for multiple gene expression in a single con-
struct), we chose to use the maize ubiquitin promoter
(Pubi, [24]) to drive the expression of a and b subunits
of rP4H. It was shown previously that there is a prefer-
ential accumulation of recombinant protein in germ tis-
sue using the ubiquitin promoter [25].
Both constructs were introduced into maize Hi II
germplasm using immature embryo via an Agrobacter-
ium-based transformation system. Twelve independent
CGB
CGD
1 kb
Figure 1 A schematic representation of the two constructs used in this study.L B ,l e f tb o r d e ro fAgrobacterium T-DNA; T35S, CaMV 35S
terminator; bar, bialaphos resistant coding sequence; P, CaMV 35S promoter; PIN II, potato protease inhibitor II gene terminator; CIa1, human
collagen I a1 chain coding sequence; BAASS, barley alpha amylase signal sequence; P4Ha, prolyl 4-hydroxylase a subunit; P4Hb, prolyl 4-
hydroxylase b subunit; Pglb, maize globulin-1 promoter; Pubi, maize ubiquitin promoter; RB, right border of Agrobacterium T-DNA.
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Page 2 of 12transgenic events for CGB and 21 events for CGD,
respectively, were recovered and brought to maturity in
the greenhouse using pollen donors from an elite
inbred. Initial transgene expression screens were con-
ducted on both callus and T1 seeds using an enzyme-
linked immunosorbent assay (ELISA) to detect the
expression of rCIa1, and a and b subunits of rP4H. T2
s e e d sf r o me v e n t sw i t ht h eh i g h e s tt r a n s g e n ee x p r e s -
sions were produced by self pollination.
For T1 seed analysis, seeds from multiple plants
derived from each event were analysed. In depth mole-
cular and biochemical characterizations of rCIa1
described in this study were performed on T2 seeds
from one selected CGB and CGD event, respectively.
Individual seeds of the transgenic events were analyzed
by polymerase chain reaction (PCR) to separate trans-
gene positive seeds from negative ones. Positive seeds
were pooled and analyzed by ELISA for the expression
of the rCIa1. Negative null segregant seeds were used as
controls.
The average expression level of rCIa1m e a s u r e db y
ELISA in event CGB was 1.86 ± 1.26 mg/g of total solu-
ble protein (TSP) or 12.14 ± 8.06 mg/kg of dry seed
weight (DSW). The highest rCIa1 content measured to
d a t ef r o mas i n g l eC G Bs e e dw a s3 . 5 4m g / gT S Po r
25.11 mg/kg DSW. The average expression level of the
rCIa1 in event CGD was about four times lower than
that of in event CGB, which was 0.58 ± 0.26 mg/g TSP
or 4.40 ± 2.09 mg/kg DSW. The highest rCIa1e x p r e s -
sion in single CGD seed was 0.92 mg/g TSP or 7.54
mg/kg DSW.
Figure 2 shows the detection of rCIa1 in the total
protein extracts from CGB and CGD seeds. Because of
the low expression level of rCIa1i nC G Ds e e d s ,w e
concentrated the extract using an Amicon Ultra-15 Cen-
trifugal Filter Unit with Ultracel-30 membrane (cat #
UFC903008, Millipore) before loading on the gel. Figure
2s h o w st h a tr C I a1 could be detected from both CGB
and CGD protein samples using anti-foldon antibody.
No cross-reacting band at a similar position could be
detected in non-transgenic maize seeds (data not
s h o w n ) .I tw a so b s e r v e dt h a tt h eC G Br C I a1m i g r a t e d
faster than its CGD counterpart (Figure 2, open arrow
in Lane CGB vs solid arrow in Lane CGD), suggesting
different electrophoretic mobility for these two proteins.
To exclude that the observed protein migration differ-
ence was due to lane shifts during electrophoresis, we
mixed the TSPs from both CGB and CGD before load-
ing on the gel. Lane CGB+CGD of Figure 2 shows there
are two distinct major bands that cross-reacted with
anti-foldon antibody. This result indicates that the
rCIa1 proteins derived from maize CGB and CGD
events have different electrophoretic mobility, with CGD
rCIa1 moves slower than CGB rCIa1. The altered elec-
trophoretic mobility may reflect the increase in molecu-
lar weight of rCIa1 that due partially to increased
numbers of hydroxylated proline in rCIa1f r o mC G D
event, which is also co-expressing the rP4H genes. The
difference in electrophoretic mobility can also been seen
in Pichia-derived rCIa1 (Figure 2, FE291) and hydroxy-
lated rCIa1 (Figure 2, FE285).
The expression of the b subunit of rP4H in the CGD
seeds was verified by Western Blotting with an anti
P4Hb monoclonal antibody (Figure 3). A main band at
~60 kD (open triangle, Figure 3) was detected in CGD,
but not in CGB and non-transgenic wild type maize
control, as expected. A weak secondary band detected in
CGD is likely due to cross-reactivity of other forms of
rP4Hb in maize. The detection of a subunit of P4H was
performed in transgenic callus but not in seeds (data
not shown).
To determine whether rCIa1 can also be detected in
tissues other than seeds, we performed both protein and
transcript analyses of rCIa1 in CGB and CGD plants.
Maize leaf samples from 5 different development stages
were collected. Total RNA and proteins were prepared
from these tissues and subjected to Reverse Transcrip-
tase PCR (RT-PCR) and ELISA, respectively. No detect-
able rCIa1 transcript and protein could be observed in
these samples (data not shown), suggesting that the
rCIa1 is not expressed in leaf tissue in both lines as
expected.
CGB CGD M M CGB+CGD FE285 FE291 M KDa KDa
150
100
150
100
Figure 2 Analysis of electrophoretic mobility difference of
rCIa1 in the CGB and CGD line. Equal volumes of total protein
extracts from seeds of CGB, CGD (10 × concentrated by volume)
and mixture of CGB+CGD extracts were loaded on the gel. The
rCIa1 from CGB and CGD lines were detected by western blot
using anti-foldon antibody. Pichia-derived rCIa1 (FE291) and rCIa1-
OH (FE285) were included as controls and detected by Coomassie
Brilliant Blue staining. Open arrows, rCIa1 from CGB or FE291; solid
arrows, OH-rCIa1 from CGD or FE285. M, molecular weight marker.
CGD WT CGB M KDa
75
50
Figure 3 Western blot analysis of the rP4Hb using anti-P4Hb
antibody. Equal volume of total protein extraction from seeds of
CGB, CGD and non-transgenic control maize (WT) extracts was
loaded on the gel. Open triangle, rP4Hb. M: molecular weight
marker.
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rCIa1
To examine the percentage and positions of the prolines
that were hydroxylated by the co-expression of rP4H in
the CGD event, we carried out proteomics analysis of
gel purified rCIa1 using liquid chromatography tandem
mass spectrometry (LC-MS/MS) on the Linear Ion Trap
Orbitrap (LTQ Orbitrap) Mass Spectrometer, a high
resolution mass spectrometry (HRMS). The HRMS not
only can verify the amino acid sequence of the rCIa1,
but also can identify the positions of hydroxylated pro-
line residues (Hyp). In addition to maize-derived rCIa1
proteins from CGB and CGD, we also included three
control samples: gel isolated CIa1 fragment from
human collagen (cat # 234138, CalBiochem Inc), Pichia-
derived rCIa1 (isolated from strain FE291 that does not
co-express rP4H) and Pichia-derived hydroxylated
rCIa1 (isolated from strain FE285 that co-express rP4H)
(FibroGen).
Results are summarized in Figure 4 and Table 1. The
protein sequence coverage by the HRMS (yellow high-
lighted sequences in Figure 4) on the five samples ran-
ged from 58.66% (human CIa1) to 85.81% (Pichia CIa1-
OH). To compare the percentages and positions of Hyp
in each sample, we chose the peptide regions in all five
CIa1 proteins (475 AA) that were covered by the
HRMS (red boxes in Figure 4). The common peptide
regions represent 44.94% of the full-length CIa1
sequence (1057 AA). A total of 114 Pro and Hyp out of
475 total amino acids (24.00%) were identified by the
HRMS in all samples (Figure 4).
For two maize-derived CIa1 samples, a total of 28 and
8 6H y pw e r ei d e n t i f i e df r o mC G Ba n dC G D( g r e e n
highlighted amino acids in Figure 4), respectively, repre-
senting a Hyp percentage of 5.89% and 18.11%, respec-
tively, for these two lines (Table 1). This result indicates
that the co-expression of rP4H in maize can greatly
enhance the hydroxylation of prolines on collagen mole-
cules. The increased number of Hyp in rCIa1f r o m
CGD samples may partially contributed to the increased
molecular weight and thereby decreased the migration
rate (Figure 2).
Because rP4H catalyzes hydroxylation of Pro residues
in the Yaa position of the Xaa-Yaa-Gly triplets within
collagen strands [26], we further compared the Pro resi-
dues on all Xaa-Pro-Gly triplets in both maize CGB and
CGD lines. HRMS analysis identified 752 AA (71.14%)
from maize-rCIa1 (CGB) and 818 AA (77.39%) from
maize rCIa1-OH (CGD) as shown in Table 1 and Figure
4 (bold and yellow highlighted letters). Among these
HRMS identified AA, we chose 652 AA that were
shared for both CGB and CGD. We further identified a
total of 90 sets of collagenous triplets within the 652
AA. Among the 90 sets of triplets, 44 sets (48.9%) have
the Pro residues changed to Hyp (double underlined tri-
p l e t si nF i g u r e4 )i nb o t hC G Ba n dC G Dl i n e s ;5s e t s
(5.6%) have the Pro unchanged (single underlined tri-
plets in Figure 4) in both lines. On the other hand, 41
sets of triplets (45.6%) have the Pro residues changed to
Hyp (black boxes in Figure 4) only in rCIa1i s o l a t e d
from CGD, indicating that nearly half of the collagenous
triplets were posttranslationally modified by the co-
expression of rP4H genes in CGD maize line.
Seventy-one Hyp residues out of 475 AA by HRMS
(14.95%) were identified in human CIa1c o n t r o ls a m p l e
(Table 1). For Pichia s a m p l e s ,w h i l eo n l yt w oH y pr e s i -
dues (0.42%) were found in non-hydroxylated CIa1
(FE291), 83 Hyp residues (17.47%) were found in hydro-
xylated CIa1 (FE285), indicating that the co-expression
of P4H in Pichia had also dramatically increased proline
hydroxylation in collagen (Table 1).
Co-expression of rP4H enhances the thermal stability of
rCIa1
To further characterize the maize-derived rCIa1a n d
rCIa1-OH, we carried out thermal stability analysis
using pepsin digestion at 10°C for 15 minutes after heat
treatment of protein samples at 4°C or temperatures
ranged from 29 to 38.6°C for 6 minutes. The proteolytic
resistance of maize-derived collagens were compared
with that of the native human collagen and the recombi-
nant collagen from Pichia pastoris.F i g u r e5 Ai saW e s -
tern Blot results showing the proteolytic resistance of
the collagens after 4°C heat treatment using anti-foldon
antibody. Both non-hydroxylated rCIa1f r o mm a i z e
(CGB) and non-hydroxylated rCIa1 from Pichia (FE291)
were not detected after pepsin treatment. By contrast,
the hydroxylated rCIa1 could be detected from both
maize (CGD) and hydroxylated-CIa1 Pichia (FE285)
samples, suggesting that the pepsin digestion resistance
of these collagens was associated with the higher per-
centage of Hyp residues.
The thermal stability of rCIa1 was further character-
ized by the determination of melting temperature (Tm)
using Western analysis. Two different antibodies, anti-
foldon and anti-25 kD collagen, were used. In our
hands, anti-foldon antibody gave results with less non-
specific cross-reactive background bands, while anti-25
kD antibody appeared to be more sensitive. Because the
native human CIa1 can only be detected with anti-25
kD antibody, we used both antibodies in this study. In
the experiments shown in Figure 5B, maize seeds TSP
from CGB and CGD were extracted and concentrated
as described above. The quantities of maize-derived
rCIa1 were estimated by ELISA. Approximately 50-100
ng/reaction of rCIa1 from CGB and CGD were used for
pepsin treatment. As a control, commercial human col-
lagen (2 μg/reaction) was spiked into TSP extracted
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Page 4 of 12                                    20                  40                  60                  80                 100 
Pichia rCIĮ1      QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
Maize rCIĮ1       QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
Human CIĮ1        QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
Maize rCIĮ1-OH    QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
Pichia rCIĮ1-OH   QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
 
                                   120                 140                 160                 180                 200 
Pichia rCIĮ1      PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
Maize rCIĮ1       PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
Human CIĮ1        PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
Maize rCIĮ1-OH    PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
Pichia rCIĮ1-OH   PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
 
                                   220                 240                 260                 280                 300 
Pichia rCIĮ1      GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
Maize rCIĮ1       GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
Human CIĮ1        GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
Maize rCIĮ1-OH    GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
Pichia rCIĮ1-OH   GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
 
                                   320                 340                 360                 380                 400 
Pichia rCIĮ1      PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
Maize rCIĮ1       PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
Human CIĮ1        PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
Maize rCIĮ1-OH    PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
Pichia rCIĮ1-OH   PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
 
                                   420                 440                 460                 480                 500 
Pichia rCIĮ1      DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
Maize rCIĮ1       DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
Human CIĮ1        DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
Maize rCIĮ1-OH    DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
Pichia rCIĮ1-OH   DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
 
                                   520                 540                 560                 580                 600 
Pichia rCIĮ1      GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
Maize rCIĮ1       GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
Human CIĮ1        GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
Maize rCIĮ1-OH    GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
Pichia rCIĮ1-OH   GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
 
                                   620                 640                 660                 680                 700 
Pichia rCIĮ1      VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
Maize rCIĮ1       VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
Human CIĮ1        VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
Maize rCIĮ1-OH    VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
Pichia rCIĮ1-OH   VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
 
                                   720                 740                 760                 780                 800 
Pichia rCIĮ1      KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
Maize rCIĮ1       KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
Human CIĮ1        KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
Maize rCIĮ1-OH    KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
Pichia rCIĮ1-OH   KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
 
                                   820                 840                 860                 880                 900 
Pichia rCIĮ1      GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
Maize rCIĮ1       GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
Human CIĮ1        GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
Maize rCIĮ1-OH    GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
Pichia rCIĮ1-OH   GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
 
                                   920                 940                 960                 980                1000 
Pichia rCIĮ1      KSGDRGETGPAGPAGPVGPAGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
Maize rCIĮ1       KSGDRGETGPAGPAGPVGPAGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
Human CIĮ1        KSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
Maize rCIĮ1-OH    KSGDRGETGPAGPAGPVGPAGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
Pichia rCIĮ1-OH   KSGDRGETGPAGPAGPVGPAGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
 
                                  1020                1040                  
Pichia rCIĮ1      IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Maize rCIĮ1       IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Human CIĮ1        IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Maize rCIĮ1-OH    IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Pichia rCIĮ1-OH   IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Figure 4 LC-MS/MS analysis of the rCIa1. Full length peptide sequences of 1057 amino acid are listed. Pichia rCIa1, Pichia-derived rCIa1 from
strain FE291; Maize rCIa1, maize-derived rCIa1 from line CGB; Human CIa1, gel-isolated CIa1 fragment from commercial collagen (CalBiochem
Inc); Maize rCIa1-OH, maize-derived rCIa1 from line CGD; Pichia rCIa1-OH, Pichia-derived rCIa1 from strain FE285. Yellow-highlighted letters:
amino acid sequences identified by the Orbitrap; green-highlighted letters: Hyp residues identified by the Orbitrap; red boxes: peptide regions
identified in all five samples by the Orbitrap. Black boxes: collagenous triplets Xaa-Pro-Gly with Pro changed to Hyp in Maize rCIa1-OH but not
in Maize rCIa1; single underlines: triplets with Pro unchanged in both maize lines; double underlines: triplets with Pro changed to Hyp in both
maize lines.
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Page 5 of 12from non-transgenic maize seed for pepsin treatment.
As can be seen in Figure 5B, both maize-derived rCIa1
(CGB) and rCIa1 - O H( C G D )w e r ea ss t a b l ea st h e
human collagen control at all temperatures tested in the
absence of pepsin. When digested with pepsin, the
maize-derived non-hydroxylated rCIa1( C G B )w a s
degraded after the heat treatment at temperatures as
low as 4°C. On the other hand, the hydroxylated rCIa1-
OH (CGD) could still be detected after temperature
treatment as high as 35°C when using anti-foldon anti-
body, and 38.6°C when using anti-25 kD antibody. The
difference in Tm results was likely due to the sensitivity
and epitope recognition sites of two types of antibodies.
Interestingly, the control native human collagen could
only withstand the digestion upto temperature treatment
around 31°C. This observation is in fact in agreement
with the HRMS analysis of the collagens described in
Table 1 and Figure 4. Because the maize-derived rCIa1-
OH has higher Hyp percentage (18.11%) than that from
human collagen control (14.95%), it is expected that the
increased Hyp residues could help to increase the ther-
mal stability of the collagen molecules.
Table 1 Summary of HRMS analysis on five CIa1 (1057 AA
1) samples from maize, Pichia and human
Pichia
CIa1 (FE291)
Maize
CIa1 (CGB)
Human
CIa1
Maize
CIa1-OH (CGD)
Pichia
CIa1-OH (FE285)
Peptides identified by HRMS (highlighted in yellow, Figure 4)
Total # AA 680 752 620 818 907
Percent HRMS coverage 64.33% 71.14% 58.66% 77.39% 85.81%
Peptide regions identified in all five C1a1 (475 AA) by HRMS (red boxes, Figure 4)
Total # HYP identified by HRMS, in green 2 28 71 86 83
Percent HYP identified by HRMS 0.42% 5.89% 14.95% 18.11% 17.47%
% HYP (by AA analysis) N/A 1.23%
2 10.8%
3 N/A 11.54%
2
1sequences presents in all five samples
2from reference [11]
3from reference [28]
+ Pepsin
CGB FE291 CGD FE285 KDa
150
M
A.
í + í + í + í
100
B.
oC 4 2 93 1 3 33 53 7 3 8 . 2 3 8 . 6 4 29 31 33 35 37 38.2 38.6 Antibody
Anti-25kD
CGB
Anti-foldon
HuC
+ Pepsin í Pepsin
CGD
Anti-foldon
Anti-25kD
Anti-25kD
Figure 5 Thermal stability analysis of the rCIa1 from maize, Pichia and human. (A) Western blot results of the maize-derived rCIa1 (CGB),
rCIa1-OH (CGD), Pichia-derived rCIa1 (FE291), and rCIa1-OH (FE285) after 4°C incubation and pepsin treatment, using anti-foldon antibody. (B)
Western blot results of the maize-derived rCIa1 (CGB), rCIa1-OH (CGD), and human CIa1 (HuC) after heat treatments under various temperatures
and pepsin treatments as indicated, using both anti-foldon and anti-25 kD collagen antibody. M: molecular weight marker.
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The production of plant-derived recombinant collagens
have been reported in tobacco leaves, barley cell culture
and seeds, as well as maize seeds as summarized in
Table 2. Previous tobacco-derived rCIa1 studies showed
that different combinations of recombinant human col-
lagens (i.e. rCIa1, rCIa2, and N-propeptide free rCIa1)
were used to improve the production of homotrimeric
or heterotrimeric recombinant human type I collagen
[10,16,17,27]. In a recent paper, Stein et al [17] achieved
a high expression level of 200 mg/kg fresh leaves by
expressing the collagens under a Chrysanthemum rbcS1
promoter and vacuolar-targeting signal sequence. Early
work with tobacco-derived collagens had very low levels
of Hyp (0.53%, [10]). With co-expression of C. elegans
P4Ha/Mouse P4Hb [16] or the human rP4Ha/b [17],
Hyp levels were increased to 8.41% and 7.55%, respec-
tively. However, this enhanced Hyp level in tobacco is
still lower than that of native human collagen CIa1,
which is reported as 10.8% by amino acid analysis [28]
or around 15% by the HRMS analysis (this work).
Both the full length and a smaller fragment (45 kD) of
rCIa1 were produced in barley cell culture [7] and bar-
ley seeds [13]. The barley-derived 45 kD collagen has
2.8% of Hyp content when produced in seeds without
co-expression of rP4H genes [13].
Previous work on fractionation, purification and char-
acterization of maize-derived full length and a smaller
fragment (44 kD) of collagen suggested that an accumu-
lation level of about 3 mg/kg (for the full length) and of
20 mg/kg (for the 44 kD) of DSW, respectively [11,29].
A similar maize line accumulating the full length rCIa1
producing maize line (CGB) was used in this study. In
our case, the collagen yield of the rCIa1 accumulating
line without P4H co-expression averages 12 mg/kg
DSW, while the rCIa1 accumulating line with P4H co-
Table 2 Summary of plant derived recombinant human collagen I a 1
Expression
system
Collagen rP4H Hydroxylation
content (%)
Reference
Regulatory sequences Gene Yield
Tobacco
Leaf
P35S (constitutive) + PR-protein SP proa1(I)
ΔNproa1(I)
30 mg/kg powdered
plants
N/A 0.53 10
Tobacco
Leaf
P35S (constitutive) + PR-protein SP ΔNproa1(I) N/A N/A N/A 27
Tobacco
Leaf
L3 + PR-protein SP ΔNproa1(I) 0.5-1 mg/kg leaf
material
P1287 + Native SP +
C. elegans
P4Ha/Mouse P4Hb
8.41 16
Tobacco rbcS1 (constitutive) + vacuole or apoplast
targeting SPs
proa1(I)/
proa2(I)
200 mg/kg fresh
leaves
P35S (constitutive) +
vacuole
or apoplast targeting
SPs +
Human P4Ha/b
7.55 17
Barley P1
cell
Ubi (constitutive) + At chitinase SP +
HDEL (ER retention)
proa1(I) 2-9 μg/L cell culture N/A N/A 7
Barley Seed GluB1 (endosperm specific) +
At chitinase SP + HDEL
(ER retention)
CIa1 45 kD Below detectable
level (CIa1)
45 mg/kg seed
(45 kD)
N/A N/A (CIa1) 2.8
(45 kD)
13
Maize Seed globulin-1 (embryo specific) +
barley a-amylase SP
44 kD 20 mg/kg seed N/A 2.01 29
Maize Seed globulin-1 (embryo specific) +
barley a-amylase SP
CIa1 3 mg/kg seed N/A 1.23 11
Maize Seed globulin-1 (embryo specific) +
barley a-amylase SP
CIa1 44 kD 15.9 mg/kg germ
(CIa1)
49.6 mg/kg germ
(44 kD)
N/A N/A 12
Maize Seed globulin-1 (embryo specific) +
barley a-amylase SP
CIa1 12 mg/kg seed
(CIa1)
4 mg/kg seed
(CIa1-OH)
Pubi (constitutive) +
Barley
a-amylase SP +
Human P4Ha/b
18.11 This study
proa1(I): human type I procollagen a 1 chain
ΔNproa1(I): human type I procollagen a 1 chain lacking N-propeptide
ΔNCproa1(I): human type I procollagen a 1 chain lacking N-propeptide and C-propeptide
CIa1: sequence information is not clear
44 kD: 44 kD fragment of CIa1
45 kD: 45 kD fragment of CIa1
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Page 7 of 12expression (CGD) is about 4 mg/kg. The Hyp percen-
tage in rCIa1 protein of CGB was reported as 1.23%
using total amino acid composition (AAC) analysis [11];
however, it was measured at 5.89% by using HRMS ana-
lysis in our study. Similarly, the Hyp percentage in
human CIa1 was reported as 10.8% using AAC analysis
[ 2 8 ] .I no u rH R M Sa n a l y s i s ,t h eH y pf o rh u m a nC I a1
measured around 15%. It is not clear why Hyp percen-
tages of CIa1 proteins measured uniformly higher in
HRMS analysis than that of in AAC analysis. This dis-
crepancy is likely due to the different degrees of resolu-
tion of these two very different methodologies. Because
the concentrations of rCIa1a n dr C I a1-OH obtained
from maize seeds were too low to be measured by AAC
analysis in our study, we were not able to obtain AAC
analysis results for comparison.
P4H is an enzyme that regioselectively modifies the
Pro residues in collagenous triplets Xaa-Pro-Gly [30,31]
in the ER as a posttranslational modification. Compared
to the Pichia recombinant protein production system,
maize can produce hydroxylated rCIa1 with a compar-
able Hyp percentage (Table 1, 18.11% in maize CGD vs
17.47% in Pichia FE285). Interestingly, rCIa1 produced
in maize seems to have a higher base-level Hyp percen-
tage when compared to rCIa1i s o l a t e df r o mPichia with
no rP4H co-expression (Table 1, 5.89% in maize CGB vs
0.42% in Pichia FE291). Small numbers of proline at
both Xaa and Yaa positions got hydroxylated in CGB
maize line without the co-expression of P4H (data not
s h o w n ) .I ti sl i k e l yt h a tt h er C I a1 produced in maize is
also a substrate for plant endogenous P4Hs with lower
efficiency [30].
Conversely, the expression of human rP4H in maize
may also catalyze hydroxylation of Pro residues in any
plant endogenous proteins with collagenous domains.
We checked amino acid sequences of three abundant
seed storage proteins (19 kD and 22 kD a-zein, and 27
kD g-zein) in maize and did not find any collagenous
triplets (X. Xu, unpublished). Therefore we do not
expect any Pro to Hyp modifications on these seed sto-
rage protein in the rP4H expressing CGD line. In fact,
the Hyp-only AAC analysis on both CGB and CGD
s e e d ss h o w e dn od i f f e r e n c e si nH y pc o n t e n t s( X .X u ,
unpublished). However, because both a and b subunits
of rP4H were under the control of the constitutive ubi-
quitin promoter, it is possible that any of the collage-
nous triplet domains on proteins in plant cells can be
modified by rP4H in such transgenic lines. It may be
desirable in the future to restrict rP4H expression to
seed tissue only using seed specific promoters.
Using HRMS to analyze posttranslational modification
has obvious advantages such as low protein quantity
requirement, free of contaminating proteins in samples
and reading accuracy. However, it does not give 100%
coverage. In this study the peptide coverage ranged
from 58.66% to 85.81%.
Because posttranslational modification is a continuous
process in the cells, the collagen isolated from the seeds
represents a population of protein molecules, i.e., the
proline hydroxylation may vary from one collagen mole-
cule to another. In fact, we have performed multiple
HRMS measurements on samples extracted from same
batch of seeds. We found that while positions of Pro to
Hyp modification may vary between measurements, the
overall Hyp content remained constant between these
samples.
The thermal stability tests in this report showed that
maize-derived rCIa1-OH could still be detected after
pepsin digestion followed by heat treatment as high as
35°C (using anti-foldon antibody) and 38.6°C (using
anti-25 kD antibody). Commercial human collagen con-
trol undergoing the same treatment could only with-
stand up to 31°C temperatures. Stein et al [17] reported
that the melting temperatures for their tobacco-derived
collagen heterotrimer and human skin collagen samples
were around 39°C. High melting temperature of plant-
derived collagen could potentially be useful for certain
industrial application where higher melting temperature
is desired, for example, biomaterials for tissue engineer-
ing [32,33].
We recovered the maize-derived rCIa1f r o mt h es e e d
total soluble proteins using a previously described proto-
col [11]. Because collagens are acid soluble proteins, the
extraction buffer used had a pH of 1.7. Unlike Zhang et
al. [11], we did not perform extensive purification for
rCIa1 before gel electrophoresis and Western blot ana-
lysis. When treating such acidic rCIa1 solutions under
high temperature as we normally do before loading pro-
tein gels, we were unable to detect them in Western
blot, suggesting that the combination of acidic buffer
and high temperature could be detrimental to collagen
integrity. Therefore in this study, all maize-derived
rCIa1 samples in acidic solutions were not boiled prior
to Western blot analysis to avoid collagen degradation.
It is interesting to note that both maize- and Pichia-
derived non-hydroxylated rCIa1 were completely
digested by pepsin at 10°C after the temperature treat-
ment of samples at 4°C in our study (Figure 5A). This
result is different from what was reported in barley [7]
and maize [11], in which plant- and Pichia-derived
rCIa1 were still detectable after the heat treatment of
26-27°C. This could be attributed to the different pepsin
treatment protocols used in the experiments. For exam-
ple, the pepsin experiments reported by Zhang et al[11]
were conducted under pH 7, with a 15 minutes heat
treatment followed by 150 μg/mL pepsin digestion at 4°
Cf o r1 6 - 1 8h r .R i t a l aet al[7] conducted the heat treat-
ment for 6 min before subjecting the samples to 150
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acidic condition. Our conditions were similar to Ritala
et al except that we used 200 μg/mL pepsin for 15 min
under pH 1.7. Because pepsin functions best in acidic
environment, our pepsin digestion under low pH is
likely leading to the degradation of non-hydroxylated
rCIa1 even at 4°C. Another explanation could be the
quantity of the collagen substrate used in different
experiments. We estimated that approximately 50-100
ng/reaction of unpurified rCIa1 from CGB seeds were
subjected to pepsin digestion in our study. However,
Zhang et al used about 600 - 700 ng purified rCIa1p e r
reaction in their study [11]. The quantity of collagen for
pepsin digestion in Ritala et al[7] was not specified.
We have demonstrated for the first time that mamma-
lian-like hydroxylation of human rCIa1 can be achieved
in transgenic maize co-expressed with a human rP4H.
The Hyp content in maize-derived hydroxylated rCIa1
is comparable to that of the native human version, lead-
ing to a similar thermal stability of the product. The
current expression levels of collagen reported here are
too low for large scale production, as desired accumula-
tion level of recombinant proteins for commercial pro-
duction is estimated between 250 to 1000 mg/kg grain
[34,35]. Further improvement of recombinant protein
production in plants can be achieved by optimization of
gene expression including using more effective regula-
tory elements and protein targeting/retention sequences,
as well as using conventional breeding program to select
high expression lines over generations [34,36].
Conclusions
In this study we have shown that properly hydroxylated
recombinant human collagen I alpha 1 (rCIa1) can be
produced in maize seed. By co-expressing recombinant
human prolyl 4-hydroxylases (rP4Hs), we have success-
fully produced rCIa1 containing Hyp residue levels that
a r ec o m p a r a b l et on a t i v eh u m a nC I a1. The increased
Hyp content is associated with increased thermal
stability in maize-derived rCIa1. Application of high-
resolution mass spectrometry (HRMS) allowed us to
measure hydroxylated prolines at specific amino acid
positions in different samples. Our findings indicate that
maize seed can be used as a system to produce recombi-
nant proteins requiring mammalian-like posttransla-
tional modifications.
Methods
Vector construction
H u m a nc o l l a g e nt y p eIa 1( C I a1) coding sequence
together with its original N- and C-telopeptides
sequences (UniProtKB/Swiss-Prot: P02452) were opti-
mized by Aptagen LLC (Jacobus, PA) for expression in
maize. The optimized CIa1 sequence was fused with a
29 amino acids bacteriophage foldon peptide sequence
[23] at the C-terminus to produce a protein with 1086
amino acids. Two constructs (Figure 1) were made to
produce either recombinant CIa1( r C I a1) only (CGB),
or both rCIa1 and recombinant human prolyl-4-hydro-
xylase (rP4H, CGD). The rCIa1 gene was regulated by a
maize embryo-specific promoter, globulin-1 [18], with a
3’-terminator from potato protease inhibitor II (pin II)
gene. Genes encoding two subunits of rP4H (rP4Ha and
rP4Hb) were regulated by a maize constitutive promoter
(ubiquitin promoter) and the potato pin II gene termi-
nator. All three gene coding sequences (rCIa1, rP4Ha,
and rP4Hb) in the two constructs were translationally
fused with a barley alpha amylase signal sequence
(BAASS, [19]) at the 5’ end. The phosphinothricin acetyl
transferase (bar) gene driven by the cauliflower mosaic
virus (CaMV) 35S promoter was adopted in both con-
structs to be a marker for the transgenic callus selection.
It confers resistance to the herbicide glufosinate ammo-
nium (bialaphos) [37-39].
Production of transgenic plants
Constructs CGB and CGD were introduced into imma-
ture embryos of Hi II maize genotype [40] via an Agro-
bacterium-based transformation system [41]. Briefly,
maize immature embryos were infected by Agrobacter-
ium strain EHA101 [42] containing the above described
vectors and selected on 3 mg/L bialaphos. Regeneration
of transgenic plants from the callus was as previously
described [20]. Seedlings were transplanted into soil in
the greenhouse and allowed to flower and produce seed
through hand-pollinations. Seed increases for multiple
events from CGB and CGD were conducted in green-
house and nursery trials. T2 transgenic maize seeds were
used for further analysis in this study.
PCR analysis of transgenic plants
Total genomic DNA was isolated by Cetyl Trimethyl
Ammonium Bromide (CTAB) method [43] from maize
leaf or seed. The presence of transgenes rCIa1, rP4Ha
and rP4Hb were detected by polymerase chain reaction
(PCR). A typical PCR reaction consists 100 ng of genomic
DNA, 0.8 mM of dNTPs, 2 mM of MgCl2,T a qD N Ap o l y -
merase buffer and 0.5 U Taq DNA polymerase (Bioline
USA Inc, Taunton, MA) in a final volume of 25 μL. PCR
was performed at the following condition for 35 cycles: 30
s denaturation at 94°C, 30 s annealing at 60°C, and 45 s
extension at 70°C. Primers for amplifying rCIa1 are x7-05
(5’-ACCAGATGGGCCGCTCTCACCTTT-3’) and x7-06
(5’-TTCCCTGGTGCCGTTGGAGCTA-3’); for rP4Ha
are x7-17 (5’-ATCTCGGCGTCGCTGATGAT-3’) and x7-
18 (5’-GTGGTCCGAGCTGGAGAACC-3’); and for
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CTCTG-3’)a n dx 7 - 1 4( 5 ’-TCACAGCTCGTCCTT-
CACGG-3’). PCR products were analyzed in 1% agarose
gel. The expected sizes of PCR products are 1308 bp
(rCIa1), 745 bp (rP4Ha) and 1531 bp (rP4Hb), respec-
tively. Gel was stained by ethidium bromide (0.5 μg/ml)
for 20 min. The products size was determined by 1 kb
DNA Ladder (cat # N3232S, New England Biolabs).
Protein extraction
Total soluble protein (TSP) from maize seeds was
extracted using an acidic buffer described by [11] for
collagen preparation. Maize seeds were ground in a cof-
fee grinder (Mr. Coffee) for 1 min. For rCIa1 extraction,
extraction buffer (0.1 M phosphoric acid, 0.15 M
sodium chloride, pH 1.7) was added in to the seed pow-
der at the ratio of 1:10 (w/v). For rP4H extraction,
extraction buffer [25 mM sodium phosphate (pH 6.6),
100 mM sodium chloride, 0.1% Triton X-100 (v/v), 1
mM EDTA, 10 μg/mL leupeptin, and 0.1 mM serine
protease inhibitor Perfabloc SC (Fluka)] was added into
the seed powder at the ratio of 1:10 (w/v). The mixture
was incubated in a shaker incubator (250 rpm, 37°C) for
0.5 hour for rCIa1 and one hour for rP4H. The mix-
tures were then centrifuged at 13,000 rpm for 10 min at
room temperature in a bench top centrifuge. The super-
natants were transferred to clean tubes for further ana-
lysis. Some protein samples were concentrated by
Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-
30 membrane (cat # UFC903008, Millipore) followed
the product instruction. In short, 15 mL of total seed
protein extraction was loaded into the filter device, cen-
trifuged at 3000 × g for approximately 2-3 hours at 4°C.
Concentrated samples were recovered by withdrawing
with a pipettor. The concentration level was measured
b yt h ev o l u m ea n dc o u l db ea d j u s t e db yt h ec o n t r o lo f
the centrifugation time.
ELISA
A competitive ELISA procedure developed by FibroGen
and described by Zhang et al. [29] was used with minor
modifications. Briefly, ELISA plates (cat # 3590, Corn-
ing) were coated overnight at 4°C with 5 ng per well of
heat-denatured (65 ± 5°C for 30 minutes) non-hydroxy-
lated rCIa1f r o mPichia pastoris (FE301,[7]) with phos-
phate buffer saline (PBS, cat # 21-040-CV, Mediatech).
After washing with washing buffer (10 mM PBS, 0.05%
Tween 20, pH 7.0), the plates were blocked with 2% dry
milk in 100 mM PBS for 1 hour at room temperature.
After 3 × washings with washing buffer, heat-denatured
samples and standard (FE301) in assay buffer (100 mM
PBS, 0.05% Tween 20, 1% dry milk, pH 7.0) were added
to the plates. The primary antibody, rabbit polyclonal
anti-25 kDa CIa1 (CA725, FibroGen), was added
immediately at a 1:4000 dilution in the assay buffer.
After 1 hour incubation at room temperature, plates
were washed 3 × with washing buffer. The goat-anti-
rabbit IgG (H+L) HRP conjugate (cat # 81-6120,
Zymed) was added at a 1:5000 dilution in the assay buf-
f e rf o l l o w e db yi n c u b a t i o na tr o o mt e m p e r a t u r ef o r1
hour. After 3 × washings with washing buffer, 100 μL/
well of Sure Blue TMB substrate solution (cat # 52-00-
01, Kirkegarrd & Perry Laboratories) were added. The
plated were then read at 620 nm on a microplate reader
(KC4, Biotek) after incubation at room temperature for
30 minutes.
Western blotting
Forty microliters of protein extract from maize seed
were mixed with 8 μL of Laemmli sample buffer (cat #
161-0737, Bio-Rad) and then loaded onto a 4-15% poly-
acrylamide SDS-PAGE gel (cat # 161-1158, Bio-Rad). To
avoid protein degradation in the combination of acidic
pH and high temperature (X. Xu, unpublished), the step
of sample boiling prior to loading was omitted. The pro-
teins separated on the gel were transferred to a 0.45 μm
nitrocellulose membrane using Bio-Rad Semidry Trans-
blotting apparatus according to the manufacturer’s
instructions. Membranes were incubated in blocking
buffer (138 mM sodium chloride, 2.7 mM potassium
chloride, pH 7.4, 0.1% Tween-20, 5% dry milk powder)
for 1 hour at room temperature on a rotary shaker. The
membrane was then incubated for 1 hour in blocking
buffer with 1:1000 dilution of anti-foldon antibody (rab-
bit anti-sera with 0.01% sodium azide) for the rCIa1,
and with 1:1000 dilution of anti-P4Hb antibody (cat #
63-164, ICN Biomedicals) for the rP4Hb. After washing
with washing buffer (138 mM sodium chloride, 2.7 mM
potassium chloride, pH 7.4, 0.05% Tween-20) 4 times (5
min each wash), the membrane was then incubated for
1 hour in blocking buffer with 1:5000 dilution of HRP-
Goat anti-rabbit IgG (H+L) secondary antibody (cat #
62-6120, Zymed) for the rCIa1, and with 1:5000 dilution
of HRP-Goat anti-mouse IgG (H+L) secondary antibody
(cat # 62-6520, Zymed) for the P4Hb. After washing the
membrane with washing buffer 4 × 5 min, the excess
buffer was then drained off and the membrane trans-
ferred into a clean container. Bands appeared after incu-
bation with horseradish peroxidase substrate, 3,3’,5 , 5 ’-
tetramethylbenzidine (cat # T0565, Sigma) within 10
minutes.
High-resolution mass spectrometry (HRMS) analysis
To prepare maize-derived rCIa1, 10 μgo ft o t a ls o l u b l e
proteins extracted from seeds was separated on the 4-
15% polyacrylamide SDS-PAGE gel followed by Bio-Safe
Coomassie Stain (cat # 161-0786, Bio-Rad). For purified
collagen control samples, three micrograms of each of
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Pichia-derived hydroxylated collagen (FE285), and
human collagen (cat # 234138, CalBiochem Inc.) were
loaded on the gel. After electrophoresis, collagen bands
were excised from the gels and sent to the Proteomics
& Mass Spectrometry Facility at Donald Danforth Plant
Science Center, St. Louis, MO for analysis. The samples
were automatically digested with trypsin performed by
MultiProbe II protein digester (PerkinElmer) in a tem-
perature-controlled enclosed environment. After diges-
tion, samples were run by LC-MS/MS on the Linear Ion
Trap Orbitrap (LTQ-Velos Orbitrap, ThermoFisher
Scientific). For post-translational modification analysis,
the numbers of Hyp and Pro from each sample were
counted and compared.
Thermal stability analysis
The melting temperature (Tm) of CIa1 samples was
determined by pepsin digestion after heat treatment [23].
Twenty-five microliters of total soluble protein extracted
from CGB and CGD maize seed was subjected to heat
treatment in a Thermocycler machine (Biometra GmbH,
Germany) at 4°C, or at temperatures ranged from 29°C to
38.6°C for 6 min. For positive controls, 1.4 μgo fPichia-
derived rCIa1 in hydroxylated (FE285) and non-hydroxy-
lated (FE291) forms, and human collagen were also trea-
ted. After heat treatment, all protein samples were then
incubated at 10°C with or without pepsin (0.2 mg/mL final
concentration, cat # P6887, Sigma) for 15 min. Digestion
results were analyzed by western blotting using anti foldon
and anti 25 kDa collagen antibodies.
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